ANXIETY II HP

Active substance: ACONITUM NAPELLUS WHOLE, ARSENIC TRIOXIDE, ATROPA BELLADONNA, OYSTER SHELL CALCIUM CARBONATE, CRUDE, ACTIVATED CHARCOAL, HUMAN BREAST TUMOR CELL, CAUSTICUM, GELSEMIUM SEMPERVIRENS ROOT, LACHESIS MUTA VENOM, MERCURY, NITRIC ACID, PHOSPHORUS, TOXICODENDRON PUBESCENS LEAF, SODIUM CHLORIDE

LIQUID · ACONITUM NAPELLUS WHOLE 30 [hp_C]/mL, ARSENIC TRIOXIDE 30 [hp_C]/mL, ATROPA BELLADONNA 30 [hp_C]/mL, OYSTER SHELL CALCIUM CARBONATE, CRUDE 30 [hp_C]/mL, ACTIVATED CHARCOAL 30 [hp_C]/mL, HUMAN BREAST TUMOR CELL 30 [hp_C]/mL, CAUSTICUM 30 [hp_C]/mL, GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/mL, LACHESIS MUTA VENOM 30 [hp_C]/mL, MERCURY 30 [hp_C]/mL, NITRIC ACID 30 [hp_C]/mL, PHOSPHORUS 30 [hp_C]/mL, TOXICODENDRON PUBESCENS LEAF 30 [hp_C]/mL, SODIUM CHLORIDE 30 [hp_C]/mL

United StatesActive

Marketing holder: Natural Creations, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

ACONITUM NAPELLUS WHOLE · 30 [hp_C]/mL
ARSENIC TRIOXIDE · 30 [hp_C]/mL
ATROPA BELLADONNA · 30 [hp_C]/mL
OYSTER SHELL CALCIUM CARBONATE, CRUDE · 30 [hp_C]/mL
ACTIVATED CHARCOAL · 30 [hp_C]/mL
HUMAN BREAST TUMOR CELL · 30 [hp_C]/mL
CAUSTICUM · 30 [hp_C]/mL
GELSEMIUM SEMPERVIRENS ROOT · 30 [hp_C]/mL
LACHESIS MUTA VENOM · 30 [hp_C]/mL
MERCURY · 30 [hp_C]/mL
NITRIC ACID · 30 [hp_C]/mL
PHOSPHORUS · 30 [hp_C]/mL
TOXICODENDRON PUBESCENS LEAF · 30 [hp_C]/mL
SODIUM CHLORIDE · 30 [hp_C]/mL

Products containing arsenic trioxide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
EU 4	Arsenic trioxide Accord arsenic trioxide EMEA/H/C/005175 Accord Healthcare S.L.U. Arsenic trioxide medac arsenic trioxide EMEA/H/C/005218 medac Gesellschaft für klinische Spezialpräparate mbH Trisenox arsenic trioxide EMEA/H/C/000388 Teva B.V. Arsenic trioxide Mylan arsenic trioxide EMEA/H/C/005235 Mylan Ireland Limited

Registration

Registration number: 43406-0004
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 43406-0004 · Verified 2026-10-09 · open in source